AP

ADAR1 Partners

Description

ADAR1 Partners operates as an investment firm.

Investor Profile

ADAR1 Partners has backed more than 4 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series D rounds (top funding stages).
  • Majority of deals are located in United States, Canada.
  • Strong thematic focus on Biotechnology, Therapeutics, Medical.
  • Led 1 rounds in the past year.

Stage Focus

  • Post Ipo Equity (75%)
  • Series D (25%)

Country Focus

  • United States (75%)
  • Canada (25%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Medical Device
  • Internet
  • Marketplace
  • Outdoors
  • Peer To Peer
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ADAR1 Partners frequently co-invest with?

AC
North America, Maryland, United States, Baltimore
Co-Investments: 1
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 3
Altos Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Second Line
North America, Louisiana, United States, New Orleans
Co-Investments: 1
CV
North America, California, United States, San Francisco
Co-Investments: 1
AP
North America, California, United States, Belmont
Co-Investments: 1
VC
North America, Georgia, United States, Alpharetta
Co-Investments: 1
iAngels
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Greenspring Associates
North America, Maryland, United States, Owings Mills
Co-Investments: 1
SC
North America, Oregon, United States, Bend
Co-Investments: 2

What are some of recent deals done by ADAR1 Partners?

Grace Therapeutics

Laval, Quebec, Canada

Grace Therapeutics is an emerging biopharmaceutical company.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityFeb 10, 2025
Amount Raised: $10,467,142
Kiora Pharmaceuticals

Salt Lake City, Utah, United States

Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityJan 31, 2024
Amount Raised: $15,000,000
Cellectar Biosciences

Madison, Wisconsin, United States

Cellectar Biosciences is a pharmaceutical research company specializing in cancer drugs.

BiotechnologyMedical DeviceTherapeutics
Post Ipo EquitySep 5, 2023
Amount Raised: $103,000,000
Outdoorsy

Austin, Texas, United States

Outdoorsy is a marketplace platform that connects RV owners with other campers.

InternetMarketplaceOutdoorsPeer to Peer
Series DJun 24, 2021
Amount Raised: $90,000,000